I conduct and collaborate in randomized trials and observational cohort studies evaluating the toxicities (types, pathogenesis, risk factors, treatment and prevention) of HIV antiretroviral therapy. In particular, I study the main metabolic complications
“I am a biomedical scientist undertaking basic and clinical research on the pathophysiology of growth plate injury and repair, which critically impacts on children’s bone growth and growth disorders. I aim to investigate the underlying mechanisms and deve
I am a pharmacologist-cell biologist-molecular biologist and chemist examining the metabolism of iron in normal and neoplastic cells and the development of iron chelators for the treatment of a wide variety of diseases eg., ?-thalassaemia, cancer and Frie
I am a neonatologist interested in improving the outcomes of graduates of neonatal intensive care units. Currently the focus of my research is stabilisation immediately following birth and my research portfolio ranges from bench-top and animal studies thr
I am a vascular surgeon. My research is centred on the following problems relevant to my patients: 1. The management of aortic aneurysm. 2. The management of occlusive atheroma, particularly unstable atheroma, aortic calcification, intermittent claudicati
I am a cancer molecular and cell biologist determining the mechanisms of anticancer drug action and resistance in both childhood and adult malignancies. My research involves the development and investigation of both in vivo and in vitro models of resistan
Prof Hall is a population health researcher investigating the public health and public policy implications of neurobiological and genetic research on alcohol and other drug use and addiction. My research includes: the social and health system implications of new pharmacological treatments for addiction arising from neurobiological and genetic research; new approaches suggested for the prevention of drug use and addiction (for example, genetic screening and vaccination); and the impact of neurobi ....Prof Hall is a population health researcher investigating the public health and public policy implications of neurobiological and genetic research on alcohol and other drug use and addiction. My research includes: the social and health system implications of new pharmacological treatments for addiction arising from neurobiological and genetic research; new approaches suggested for the prevention of drug use and addiction (for example, genetic screening and vaccination); and the impact of neurobiological and genetic research findings on public understanding of, attitudes towards, and support for, different social policies that aim to deal with drug use and addiction.Read moreRead less
Combating The Global Medical Challenge Caused By Gram-negative 'superbugs': From Redeveloping The Polymyxins To Discovering Novel Antibiotics
Funder
National Health and Medical Research Council
Funding Amount
$375,012.00
Summary
Bacterial �superbugs� are becoming a major global medical challenge. Polymyxins are the last-line antibiotics against Gram-negative �superbugs� but with little pharmacological information available. I am an antimicrobial pharmacologist specialised in re-developing polymyxins, and discovering novel antibiotics against these very troublesome bacteria. My research targets the _Bad Bugs, No Drugs� disaster highlighted by the Infectious Diseases Society of America and the World Health Organization.